MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    The PDSAFE falls prevention programe for people with Parkinson’s: A multicentre randomised controlled trial

    A. Ashburn, R. Pickering, L. Rochester, H. Roberts, C. Ballinger, S. Hulbert, I. Marian, C. Fitton, E. McIntosh, V. Goodwin, A. Nieuwboer, S. Lamb, K. Chivers Seymour (Southampton, United Kingdom)

    Objective: The aim was to examine the effectiveness of an exercise and strategy based intervention (PDSAFE) for fall reduction. Background: Evidence suggests exercise-based interventions might…
  • 2018 International Congress

    STN deep brain stimulation can directly suppress levodopa-induced dyskinesia in Parkinson’s disease

    J. Li, Y. Zhang (Beijing, China)

    Objective: The study aims to evaluate the effect of bilateral STN-DBS on levodopa-induced peak-dose dyskinesia in patients with PD. Background: Dyskinesia is among the most…
  • 2018 International Congress

    The correlation studies between cholinergic cognitive impairment of Parkinson’s disease and the cortex thickness of brain

    Y. Zhang, B. Li (Guang Zhou, China)

    Objective: To determine whether cognitive domain impairment of visuospatial, memory, attention is related to dysfunction of brain cholinergic neurotransmitter system in mild cognitive impairment of…
  • 2018 International Congress

    A study of correlation between screening tools for cognitive decline and gait status using three-dimensional gait analysis

    PJ. Park (Busan, Republic of Korea)

    Objective: The objective of this study is to evaluate the correlation between screening tool for dementia and gait status. Background: Gait impairment in patient with…
  • 2018 International Congress

    Mild to moderate dyskinesia is not significantly related to the level of activity engagement or quality of life of patients with Parkinson’s disease

    E. Goubault, S. Bogard, K. Lebel, C. Duval (Montréal, QC, Canada)

    Objective: This cross-sectional study aimed at determining the relation between levels of drug-induced dyskinesia (DID), tremor, rigidity, bradykinesia, postural instability, as well as cognition and…
  • 2018 International Congress

    Future doctors as health educators: Undergraduate medical students raise awareness and unite for Parkinson’s disease

    S. El-Jaafary, H. Amer, A. Fouad, B. Tawfiq, L. El Sabbahy, A. Bayoumy, B. Abulkarim, B. Gamal, H. Nafea, H. Shehata, M. El-Tamawy (Cairo, Egypt)

    Objective: To highlight the role of undergraduate students in raising the awareness about Parkinson's disease among peers and public. Encouraging the students to take responsibility…
  • 2018 International Congress

    The establishment of Deep Brain Stimulation Nurse Association (DBSNA) in United Kingdom (UK)

    J. Candelario-Mckeown, L. Partington-Smith, U. Brechany, L. Mooney-Messer, J. Kausar, B. Forrow, S. Perides, L. Nelson (London, United Kingdom)

    Objective: This is a qualitative analysis in the establishment of DBSNA for specialist nurses working in neuromodulation in the UK. Background: Surgical movement disorder nurses…
  • 2018 International Congress

    Intronic pentanucleotide TTTCA repeat insertion in SAMD12 gene causes familial cortical myoclonic tremor with epilepsy type 1

    Y. Chen, ZD. Cen, XS. Zheng, F. Xie, XD. Yang, XJ. Lu, ZY. Ouyang, HW. Wu, S. Chen, HM. Yin, X. Qiu, S. Wang, MP. Ding, YL. Tang, C. Jiao, CY. Liu, JF. Xiao, W. Luo (Hangzhou, China)

    Objective: To identify the causative mutation in pedigrees with familial cortical myoclonic tremor with epilepsy (FCMTE) type 1. Background: FCMTE is an autosomal dominant neurodegenerative…
  • 2018 International Congress

    New Nomenclature Of Genetic Myoclonus Syndromes

    S. Veen, R. Zutt, C. Klein, C. Marras, S. Berkovic, J. Caviness, H. Shibasaki, T. De Koning, M. Tijssen (Groningen, Netherlands)

    Objective: In collaboration with the International Parkinson and Movement Disorder Task Force for Nomenclature of Genetic Movement Disorders, we present a new classification of genetically…
  • 2018 International Congress

    Exploring the neural correlates of gait asymmetry in idiopathic REM Sleep Behaviour Disorder

    K. Ehgoetz Martens, E. Matar, J. Hall, M. Georgiades, M. Gilat, J. Shine, S. Lewis (Camperdown, Australia)

    Objective: Given the typical asymmetric onset of motor symptoms in PD, the current study sought to investigate whether patients with iRBD show evidence of asymmetric…
  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley